Arrowhead Pharmaceuticals, Inc.

STRS OHIO ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/2/2026

Shares

31,500

Value ($000)

2,091

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/2/2026	2,091	0.0%	31,500	12/31/2025
2025 Q3	10/30/2025	355	0.0%	10,300	9/30/2025
2025 Q2	8/4/2025	19	0.0%	1,200	6/30/2025
2024 Q2	8/5/2024	600	0.0%	23,100	6/30/2024
2024 Q1	5/13/2024	735	0.0%	25,700	3/31/2024
2023 Q4	1/30/2024	872	0.0%	28,500	12/31/2023
2023 Q3	10/26/2023	714	0.0%	26,600	9/30/2023
2023 Q2	7/31/2023	948	0.0%	26,600	6/30/2023
2023 Q1	4/27/2023	665	0.0%	26,200	3/31/2023
2022 Q4	1/26/2023	1,383	0.0%	34,100	12/31/2022
2022 Q3	10/27/2022	1,127	0.0%	34,100	9/30/2022
2022 Q2	7/25/2022	1,433	0.0%	40,700	6/30/2022
2022 Q1	4/21/2022	1,816	0.0%	39,500	3/31/2022
2021 Q4	1/24/2022	2,207	0.0%	33,300	12/31/2021
2021 Q3	10/22/2021	1,954	0.0%	31,300	9/30/2021
2021 Q2	7/26/2021	2,608	0.0%	31,500	6/30/2021
2021 Q1	4/23/2021	1,783	0.0%	26,900	3/31/2021
2020 Q4	1/25/2021	1,964	0.0%	25,600	12/31/2020
2020 Q3	12/14/2020	960	0.0%	22,300	9/30/2020
2020 Q2	7/23/2020	1,407	0.0%	32,600	6/30/2020
2020 Q1	4/23/2020	1,070	0.0%	37,200	3/31/2020
2019 Q4	1/24/2020	2,061	0.0%	32,500	12/31/2019